NASDAQ$CCNE
CNB Financial Corporation · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
CNB Financial Corporation reported strong first quarter earnings, driven by loan growth and diligent investment activities.
CNB Financial Corporation reported a net income available to common stockholders of $14.2 million, or $0.84 per diluted common share, for the quarter ended March 31, 2022. The corporation experienced robust loan growth and strategic investment activities, contributing to a positive first quarter performance.
- Net income available to common was $14.2 million, or $0.84 per diluted common share, an increase compared to Q1 2021.
- Loan portfolio totaled $3.6 billion, excluding syndicated loans and PPP loans, representing an increase of $127.0 million from December 31, 2021.
- Total deposits were $4.7 billion, reflecting a slight decrease from December 31, 2021, while non-interest bearing deposits increased.
- Total nonperforming assets decreased to $20.1 million, or 0.38% of total assets.
Headline financials
Revenue & EPS history
CNB Financial · Revenue · Quarterly
$52.3M
Forward guidance
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to CNB’s financial condition, liquidity, results of operations, future performance and business.
Tailwinds
- The Corporation’s regulatory capital ratios exceeded regulatory “well-capitalized” levels.
- The Corporation continues to support the Corporation's growth strategy.
- The Corporation’s team hard work enables another strong performance for CNB.
- The Corporation's loan growth across all of our markets.
- The Corporation's diligent investment activities during our first quarter have positioned a portion of our excess liquidity into higher earning assets.
Headwinds
- The duration, severity and scope of the COVID-19 pandemic and its impact on our customers and demand for financial services
- Actions governments, businesses and individuals take in response to the pandemic
- The direct and indirect economic effects of the pandemic and containment measures
- Treatment developments, public adoption rates of COVID-19 vaccines, including booster shots, and their effectiveness against emerging variants of COVID-19, including the Delta and Omicron variants
- The pace of recovery when the COVID-19 pandemic subsides
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-0.1%
Avg return
Earnings day
+1.7%
Avg return
5 days after
+3.6%
Avg return
30 days after
45%
30 / 66 earnings
Positive
+9.7%
Q2 2020
Best reaction
-10.5%
Q2 2010
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.2% | -2.6% | -0.6% | |
| Q4 2025 | -0.8% | +4.5% | +3.5% | |
| Q3 2025 | -0.7% | +0.3% | +6.0% | |
| Q2 2025 | -0.5% | -0.8% | +2.4% | |
| Q1 2025 | +0.1% | +0.4% | -0.7% | |
| Q4 2024 | +0.9% | -1.5% | -1.8% | |
| Q3 2024 | +2.5% | +1.9% | +11.0% | |
| Q2 2024 | +0.3% | +8.1% | -3.3% | |
| Q1 2024 | -4.6% | -3.1% | +4.7% | |
| Q4 2023 | +2.4% | +3.7% | -8.0% | |
| Q3 2023 | +1.4% | +1.9% | +18.3% | |
| Q2 2023 | -0.5% | -0.7% | -3.6% | |
| Q1 2023 | -1.8% | -0.4% | -1.9% | |
| Q4 2022 | -0.8% | -1.5% | +2.9% | |
| Q3 2022 | -1.1% | -4.5% | +2.2% | |
| Q2 2022 | +4.1% | +3.2% | +17.6% | |
| Q1 2022 | +5.2% | +4.9% | -2.7% | |
| Q4 2021 | +2.4% | +1.1% | +0.1% | |
| Q3 2021 | +5.1% | +5.8% | +14.9% | |
| Q2 2021 | +2.0% | +2.6% | +11.2% | |
| Q1 2021 | -3.5% | +2.5% | +0.2% | |
| Q4 2020 | -8.0% | -6.4% | +7.2% | |
| Q3 2020 | +6.3% | +21.9% | +22.8% | |
| Q2 2020 | +9.7% | +8.9% | +6.2% | |
| Q1 2020 | -4.1% | -2.3% | -2.7% | |
| Q4 2019 | -0.6% | -4.4% | -8.2% | |
| Q3 2019 | +0.8% | +11.9% | +10.8% | |
| Q2 2019 | -0.3% | +5.3% | +1.8% | |
| Q1 2019 | -1.4% | +0.1% | -0.5% | |
| Q4 2018 | +2.8% | +2.9% | +13.3% | |
| Q3 2018 | -1.9% | -8.6% | -5.3% | |
| Q2 2018 | +0.7% | +2.7% | +2.2% | |
| Q1 2018 | -0.1% | +0.1% | +3.0% | |
| Q4 2017 | -4.5% | -1.4% | +3.0% | |
| Q3 2017 | +1.1% | +2.3% | +0.4% | |
| Q2 2017 | +3.5% | +5.4% | -2.7% | |
| Q1 2017 | +6.8% | +9.2% | -3.2% | |
| Q4 2016 | -5.2% | -6.8% | -2.9% | |
| Q3 2016 | -0.1% | +2.2% | +21.1% | |
| Q2 2016 | -1.1% | -1.1% | +4.4% | |
| Q1 2016 | +0.1% | — | — | |
| Q4 2015 | -1.4% | — | — | |
| Q3 2015 | +0.0% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | +0.4% | — | — | |
| Q4 2014 | -0.1% | — | — | |
| Q3 2014 | -1.7% | — | — | |
| Q2 2014 | +3.9% | — | — | |
| Q1 2014 | +1.0% | — | — | |
| Q4 2013 | -1.8% | — | — | |
| Q3 2013 | +7.2% | — | — | |
| Q2 2013 | +1.1% | — | — | |
| Q1 2013 | -3.8% | — | — | |
| Q4 2011 | +0.2% | — | — | |
| Q4 2009 | +0.2% | — | — | |
| Q4 2010 | +0.2% | — | — | |
| Q4 2012 | -1.4% | — | — | |
| Q3 2012 | -0.3% | — | — | |
| Q2 2012 | -1.8% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q1 2012 | +3.7% | — | — | |
| Q3 2010 | -3.7% | — | — | |
| Q3 2011 | -3.7% | — | — | |
| Q2 2011 | -10.5% | — | — | |
| Q2 2010 | -10.5% | — | — | |
| Q1 2010 | +3.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro